Drug Research
Baxter announced the launch of a ready-to-use VANCOMYCIN Injection in sodium chloride for US
Only Manufacturer to Offer the Antibiotic in a Ready-to-Use Premixed Presentation World pharma today/Press releases /-Advancing Baxter’s longstanding commitment to provide hospitals...
Drug Research
Boehringer Ingelheim and Eli Lilly company plans to conduct Jardiance® (empagliflozin) to be studied for the treatment of people with chronic heart failure
New studies will evaluate the effect of JARDIANCE for the treatment of chronic heart failure There are approximately 26 million people worldwide, and...
Articles
Top 5 Ways to Avoid Drug Errors
Every month millions of Americans pick up their prescription at the pharmacy, only to discover that their pill looks different than the month before. Last...
Articles
The Specialty Pharmacy: A One-to-One Personalized Approach
Maybe you’ve noticed: medications are getting more complicated, more personalized, and more expensive.
Look at some of the recent drugs approved for cancer, hepatitis C virus,...
Articles
Diabetes Symptoms & Complications
Symptoms
People with type 1 or type 2 diabetes may have a range of symptoms. These symptoms might include:
Frequent urination (polyuria) -- often at night...
Articles
Diabetes Risk Factors & Prevention
Risk Factors
Risk factors are characteristics that can predispose you to developing a condition or disease. Just because you have one or more risk factors does...
Drug Research
Neos Therapeutics Announces FDA Approval of Adzenys XR-ODT (Amphetamine Extended-Release Orally Disintegrating Tablet) for ADHD
Neos Therapeutics, Inc, a pharmaceutical company with a late‐stage pipeline of innovative extended-release (XR) product candidates for the treatment of attention-deficit/hyperactivity disorder (ADHD) announced that...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.